car-t updates at costem 2021
Published 2 years ago • 33 plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
1:33
patient selection for car-t in all
-
6:50
an overview of the immunotherapy landscape in aml: antibodies, bispecifics, & car-t
-
3:25
updates from embt 2021: hsct, car-t and covid-19
-
1:42
car-t updates in aml and all
-
11:18
car-t cells: engineered cancer killers
-
41:39
2022 wmif | the cell therapy landscape | car-t to stem cells
-
1:04:15
simplifying gmp car t and car nk cell therapy manufacturing processes [webinar]
-
0:51
developing universal car-t therapies for t-all
-
1:53
phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma
-
3:08
current car-t treatments for t-all and next steps
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
1:06
car t-cell manufacturing: the ucl group's experience
-
0:51
car-t as a frontline standard of care in all?
-
3:15
key updates in car-t therapy from eha 2022
-
3:10
universal car-t therapy for t-all
-
1:21
anti-cd22 car t-cell therapy for all: trial update, utility for salvage and cd19 status
-
1:22
update on car t-cell therapy at the city of hope
-
1:43
management of car-t related side effects
-
1:55
developing the next generation of car-t cells
-
3:43
the future of car-t therapy
-
3:14
car-t trials to watch in china